A recent Swedish meta-study found that antihypertensive treatment reduced the risk of mortality and cardiovascular morbidity in diabetic patients with systolic blood pressure above 140 mmHg. However, in patients with systolic blood pressure below 140 mmHg, further lowering of blood pressure may increase the risk of cardiovascular death, and no additional beneficial effects were observed. Insight: Patients with diabetes need to set individualized blood pressure lowering goals under the guidance of an endocrinologist based on co-morbidities such as coronary artery disease, cerebral infarction, nephropathy and fundus disease, as well as age to prevent overkill, and frequent monitoring of blood pressure at regular intervals.